why choose us

First received: January 21, 2025

Clinical Trial: A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Volunteers

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-Label, 4-Part Trial to Assess the Drug-Drug Interaction Between Zasocitinib and Combined Oral Contraceptives, a MATE Substrate, a P-gp Substrate, and a Proton-Pump Inhibitor in Healthy

Brief Summary: The main aim of this study is to find out how zasocitinib (TAK-279) interacts with other medicines taken by mouth (orally).This will be examined by how the body processes medicines, which is called pharmacokinetics or PK.In this study, other medicines that will be administered together with zasocitinib include a contraceptive (levonorgestrel (LNG) and ethinyl estradiol [EE]), a medicine for diabetes (metformin), a medicine used for heart problems (digoxin), and a medicine that blocks the production of stomach acid…

Read more